Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00132249 · ClinicalTrials.gov registry record

Vietnam Head Injury Study - Phase III

A clinical trial, sponsored by U.S. Army Medical Research and Development Command.

Completed
Registry status
254
Enrollment target

NCT00132249 is a clinical trial that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 254 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00132249 has completed, sponsored by U.S. Army Medical Research and Development Command.

COMPLETED
Registry status
254 participants
Enrollment target

Study Summary

The Vietnam Head Injury Study (VHIS)-Phase III is a prospective, long-term follow-up study of head-injured Vietnam veterans. The purpose of this research study is to determine the long-term consequences, if any, of head injury.

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2004-04
Est. Completion 2010-09

What the Registry Record Tells You About NCT00132249

The ClinicalTrials.gov registry entry for NCT00132249 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00132249 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00132249 about?

NCT00132249 is a clinical study titled "Vietnam Head Injury Study - Phase III". The Vietnam Head Injury Study (VHIS)-Phase III is a prospective, long-term follow-up study of head-injured Vietnam veterans. The purpose of this research study is to determine the long-term consequences, if any, of head injury.

What is the current status of trial NCT00132249?

This trial is currently completed. The enrollment target is 254 participants. The study started on 2004-04. Estimated completion is 2010-09.

Who is sponsoring clinical trial NCT00132249?

This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.